Trials / Completed
CompletedNCT02857062
To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin
An Open Label, In-use Tolerance Study in Babies and Children With Dry/Atopic and Very Dry/Atopic Skin, to Evaluate the Acceptability and Skin Tolerability of E45 Eczema Repair Emollient for the Treatment of Atopic or Eczema Prone Skin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited · Industry
- Sex
- All
- Age
- 3 Months – 12 Years
- Healthy volunteers
- Accepted
Summary
The investigation will evaluate, under dermatological control, the cutaneous in-use tolerance of E45 Eczema Repair Emollient with two or three times daily application, over a period of two weeks on children and babies with dry/atopic and very dry/atopic skin.
Detailed description
The investigation is an open label, in-use cutaneous tolerance investigation in children and babies with dry/atopic and very dry/atopic skin, to evaluate the acceptability and skin tolerability of E45 Eczema Repair Emollient. The investigation will be an 'at home' user investigation where the test product will be applied by the parent/legal guardian to a pre-defined test site (arm or leg) between 2 to 3 times daily, consecutively for 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | E45 Eczema Repair Emollient | E45 Eczema Repair Emollient |
Timeline
- Start date
- 2016-11-23
- Primary completion
- 2017-02-02
- Completion
- 2017-02-02
- First posted
- 2016-08-05
- Last updated
- 2017-02-08
Source: ClinicalTrials.gov record NCT02857062. Inclusion in this directory is not an endorsement.